These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 18846980
21. Hematopoietic cytokines in the sera of patients with pancreatic cancer. Mroczko B, Szmitkowski M, Wereszczyńska-Siemiatkowska U, Jurkowska G. Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207 [Abstract] [Full Text] [Related]
22. Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer. Mroczko B, Szmitkowski M, Wereszczynska-Siemiatkowska U, Jurkowska G. Clin Chem Lab Med; 2004 Mar; 42(3):256-60. PubMed ID: 15080556 [Abstract] [Full Text] [Related]
23. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC. J Clin Oncol; 2004 Oct 15; 22(20):4059-66. PubMed ID: 15381683 [Abstract] [Full Text] [Related]
24. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Suzuki M, Ohwada M, Sato I, Nagatomo M. Oncology; 1995 Oct 15; 52(2):128-33. PubMed ID: 7854772 [Abstract] [Full Text] [Related]
25. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M. Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603 [Abstract] [Full Text] [Related]
26. Hematopoietic growth factors in colorectal cancer patients. Mroczko B, Szmitkowski M, Okulczyk B. Clin Chem Lab Med; 2003 May 01; 41(5):646-51. PubMed ID: 12812262 [Abstract] [Full Text] [Related]
27. [Macrophage-colony stimulating factor and ovarian cancer]. Menditto A, Piscittelli V, Cassese F, Balbi GC, Balbi C, Cardone A. Minerva Ginecol; 1999 May 01; 51(7-8):261-4. PubMed ID: 10536419 [Abstract] [Full Text] [Related]
28. Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Groblewska M, Mroczko B, Wereszczyńska-Siemiatkowska U, Myśliwiec P, Kedra B, Szmitkowski M. Clin Chem Lab Med; 2007 May 01; 45(1):30-4. PubMed ID: 17243911 [Abstract] [Full Text] [Related]
29. Granulocyte-macrophage-colony stimulating factor in patients with colorectal cancer. Mroczko B, Szmitkowski M, Okulczyk B, Piotrowski Z. Folia Histochem Cytobiol; 2001 May 01; 39 Suppl 2():110-1. PubMed ID: 11820563 [Abstract] [Full Text] [Related]
32. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary. Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I. Gynecol Oncol; 2000 Jun 01; 77(3):405-9. PubMed ID: 10831350 [Abstract] [Full Text] [Related]
33. Serum sICAM-1 (soluble intercellular adhesion molecule-1) and M-CSF (macrophage colony-stimulating growth factor) throughout monitoring of 34 non-serous ovarian cancers. Callet N, Delaunay J, Pichon MF. Eur J Gynaecol Oncol; 2000 Jun 01; 21(2):135-40. PubMed ID: 10843471 [Abstract] [Full Text] [Related]
34. Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients. Lawicki S, Gacuta-Szumarska E, Będkowska GE, Szmitkowski M. Growth Factors; 2012 Dec 01; 30(6):357-66. PubMed ID: 22988839 [Abstract] [Full Text] [Related]
35. Circulating macrophage colony stimulating factor as a marker of tumour progression. McDermott RS, Deneux L, Mosseri V, Védrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X, Beuzeboc P, Pouillart P, Scholl SM. Eur Cytokine Netw; 2002 Dec 01; 13(1):121-7. PubMed ID: 11956031 [Abstract] [Full Text] [Related]
36. Hematopoietic cytokines as tumor markers in gynecological malignancies: a multivariate analysis with ROC curve in endometrial cancer patients. Lawicki S, Będkowska GE, Gacuta-Szumarska E, Szmitkowski M. Growth Factors; 2012 Feb 01; 30(1):29-36. PubMed ID: 22010785 [Abstract] [Full Text] [Related]
37. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW. Clin Cancer Res; 1995 Mar 01; 1(3):313-25. PubMed ID: 9815987 [Abstract] [Full Text] [Related]
38. Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis. Lubowicka E, Zbucka-Kretowska M, Sidorkiewicz I, Zajkowska M, Gacuta E, Puchnarewicz A, Chrostek L, Szmitkowski M, Ławicki S. Pathol Oncol Res; 2020 Apr 01; 26(2):791-800. PubMed ID: 30820752 [Abstract] [Full Text] [Related]
39. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L, Chang XH, Ye X, Zhu LR, Zhao Y, Tian L, Cheng HY, Li XP, Zhang H, Liao QP, Fu TY, Cheng YX, Cui H. Zhonghua Fu Chan Ke Za Zhi; 2008 Dec 01; 43(12):931-6. PubMed ID: 19134334 [Abstract] [Full Text] [Related]
40. [Macrophage-colony stimulating factor (M-csf) in diagnostic and monitoring of non-small-cell lung cancer (NSCLC)]. Mroczko B, Szmitkowski M. Pol Arch Med Wewn; 2001 Mar 01; 105(3):203-9. PubMed ID: 11680264 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]